Best Phosphodiesterase 4 Inhibitor for pulmonary disease, chronic obstructive
2 Phosphodiesterase 4 Inhibitor drugs indicated for pulmonary disease, chronic obstructive, ranked by our independent rating. The current highest-rated is daliresp. Compare them with all treatments for pulmonary disease, chronic obstructive or the full Phosphodiesterase 4 Inhibitor class. Not medical advice — always consult a professional.
Top phosphodiesterase 4 inhibitor for pulmonary disease, chronic obstructive: 1. Daliresp · 2. Zoryve
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Daliresp | Not yet rated | Prescription | $10 | View → |
| 2 | Zoryve | Not yet rated | Prescription | $10 | View → |
Full ranking · 2 drugs
Frequently asked
- What is the best phosphodiesterase 4 inhibitor for pulmonary disease, chronic obstructive?
- By our independent rating, daliresp currently ranks highest among Phosphodiesterase 4 Inhibitor drugs used for pulmonary disease, chronic obstructive. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which phosphodiesterase 4 inhibitor drugs treat pulmonary disease, chronic obstructive?
- pharmaranks lists 2 Phosphodiesterase 4 Inhibitor products indicated for pulmonary disease, chronic obstructive, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.